Monteagudo-Sánchez B, Peteiro A, Fachal C, Allegue F, Ortiz-Rey JA

Idioma: Español
Referencias bibliográficas: 16
Paginas: 208-210
Archivo PDF: 188.34 Kb.

RESUMEN

El síndrome de Muir-Torre es una genodermatosis de herencia autonómica dominante. Se asocian múltiples tumores viscerales de bajo grado, normalmente carcinomas colorrectales, con tumores sebáceos de la piel. Representa la expresión fenotípica del cáncer de colon familiar no asociado a poliposis. El síndrome de Muir-Torre podría ser el resultado de una mutación en los genes responsables de la reparación del ADN e inestabilidad de microsatélites. Describimos 2 casos de síndrome de Muir-Torre y mostramos el análisis inmunohistoquímico de las neoplasias sebáceas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Akhtar S, Oza KK, Khan SA, Wright J. MuirTorre syndrome: Case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 1999;41:681-6.

2. Pettey AA, Walsh JS. Muir-Torre syndrome: a case report and review of the literature. Cutis 2005;75:149-55.

3. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25 year retrospect. J Am Acad Dermatol 1995;33:90-104.

4. Moura C, Pecegueiro MM, Sachse MF, Amaro J, Fonseca I, Fernandes A, Vau N. Report of a case of Muir-Torre síndrome. J Eur Acad Dermatol Venereol 2002;16:638-40.

5. Lynch HT, Fusaro RM. The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): a classic obligation in preventive medicine. J Am Acad Dermatol 1999;41:797-9.

6. Harrington CR, Egbert BM, Swetter SM. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. Dermatol Surg 2004;30:817-9.

7. Gómez-Centeno P, Rodríguez López JA, García-Costa A, Álvarez López J, Cabo Gómez F, Veiga Codesido C, Fonseca Moretón A, Gómez Domínguez JM. Síndrome de Muir-Torre. Actas Dermosifiliogr 2003;94:42-4.

8. Kruse R, Rütten A, Hosseiny-Malayeri HR, Bisceglia M, Friedl W, Propping P, Ruzicka T, Mangold E. “Second hit” in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation. J Invest Dermatol 2001;116:463-5.

9. Kruse R, Rütten A, Schweiger N, Jakob E, Mathiak M, Propping P, Mangold E, Bisceglia M, Ruzicka. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 2003;120:858-64.

10. Hussein MR, Wood GS. Microsatellite instability and its relevance to cutaneous tumorigenesis. J Cutan Pathol 2002;29:257-67.

11. Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001;116:246-53.

12. Machin P, Catasus L, Pons C, Munoz J, Conde-Zurita JM, Balmana J et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002;29:415-20.

13. Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Sánchez RL. Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol 2003;30:178-84.

14. Fiorentino DF, Nguyen JC, Egbert BM, Swetter SM. Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. J Am Acad Dermatol 2004;50:476-8.

15. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJA. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as marked for Muir-Torre syndrome. Clin Cancer Res 2000;6:1784-9.

16. Curry ML, Eng W, Lund K, Paek D, Cockerell CJ. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol 2004;26:217-21.